Sun Pharma
May 25, 2012 at 11:46 | Source: Moneycontrol.com
May 25, 2012 at 09:17 | Source: Moneycontrol.com
May 25, 2012 at 08:19 | Source: Moneycontrol.com
May 22, 2012 at 12:45 | Source: Moneycontrol.com
May 18, 2012 at 12:58 | Source: Moneycontrol.com
May 03, 2012 at 20:20 | Source: Moneycontrol.com
News across the web »
May 27, 2012 at 15:22 | Source: Economic Times
May 26, 2012 at 08:01 | Source: FirstPost
May 25, 2012 at 22:26 | Source: FirstPost
May 25, 2012 at 14:45 | Source: Economic Times
May 25, 2012 at 13:26 | Source: Money Rediff News Report
Interact & exchange stock tips & market info »
Related News »
Mumbai: Drug maker Sun Pharmaceutical Industries Ltd’s Israeli subsidiary Taro Pharmaceutical Industries Ltd almost doubled its net profit to $47.3 million in the January-March quarter. The company had posted a net profit of $25.7 million in the year-ago ...
May 25, 2012 at 09:16 | Source: Livemint.com
Sun Pharmaceutical Industries announced that it has bagged nod from the US health watchdog to market its generic edition of Astelin, utilized in addressing nasal allergies, in the US market. The pharma giant has got authorization from the USFDA for its ...
May 25, 2012 at 07:28 | Source: Top News India
The BSE Sensex and NSE Nifty stayed lower amid choppy trade, due to somewhat profit booking in ICICI Bank and Reliance Industries. Infosys, ONGC, HDFC and TCS too were down in morning trade whereas the upmove in Bharti, and capital goods stocks ...
May 25, 2012 at 04:29 | Source: MoneyControl.com
New Delhi: Sun Pharmaceutical Industries today said it has received approval from the US health regulator to sell its generic version of Astelin, used in treating nasal allergies, in the American market. The company has received approval from ...
May 25, 2012 at 04:51 | Source: zeenews.india.com
Mumbai, May 24, 2012: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) announced that the USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) for its ...
May 24, 2012 at 11:40 | Source: Phramalive.com
Drug firms Dr Reddy's Laboratories, Sun Pharma and Aurobindo Pharma today said they have received US health regulator's approval to sell generic Plavix, used in treating heart diseases, in the American market. Dr Reddy's said it has launched clopidogrel ...
May 18, 2012 at 09:09 | Source: Business Standard
Mumbai, May 18, 2012: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) announced that the USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) for its ...
May 18, 2012 at 11:54 | Source: Phramalive.com
Sun Pharmaceutical Industries Limited's subsidiary has received approval from USFDA for its Abbreviated New Drug Application (ANDA) for its generic version of Astelin®, Azelastine HCL Nasal Spray, 0.1% (137 mcg/spray). This generic Azelastine ...
May 24, 2012 at 07:58 | Source: equitybulls.com
Indian pharma majors viz Dr Reddy's Laboratories, Sun Pharmaceuticals, Aurobindo Pharma and Torrent Pharma have benefited from approval of generic versions of the blood thinning drug Plavix (clopidogrel bisulfate) by US FDA along with other international ...
May 18, 2012 at 06:46 | Source: pharmabiz.com
The US Food and Drug Administration (FDA) yesterday approved selling of generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), the world's second-best-selling medicine, marketed jointly by Bristol-Myers Squibb Co and Sanofi SA.
May 19, 2012 at 08:54 | Source: domain-b.com